Literature DB >> 6757064

Bacterial and fungal infection in children with fulminant hepatic failure: possible role of opsonisation and complement deficiency.

V F Larcher, R J Wyke, A P Mowat, R Williams.   

Abstract

Serious bacterial infection, including eight episodes of bacteraemia, developed in seven of 15 (47%) children with fulminant hepatic failure. Those with infections had a slightly higher leucocyte response than those who did not. Serum immunoglobulin concentrations were normal or raised in all patients. Opsonisation of heat-killed baker's yeast, functionally measured total haemolytic complement, C4, C5, total alternative pathway activity, factor B and D activity, and C3 concentrations were all significantly (p less than 0.005) reduced at presentation but returned to normal in those who survived. The severity of defects in yeast opsonisation, C4, and factor B activity at presentation were significantly correlated with the subsequent development of infection. In five patients bacteraemia occurred at a time when opsonisation and complement components were defective. Plasma infusions in vivo improved opsonisation in vitro and only one bacterial isolate was obtained within four days of such an infusion. Those patients who developed infection had received significantly (p less than 0.05) fewer plasma infusions than those who did not. Our findings suggest that both alternative and classical pathways of complement are defective in children with severe liver disease and may contribute to the susceptibility of such patients to infections. Plasma infusions might be useful in reducing the incidence of bacterial infection in such conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757064      PMCID: PMC1419842          DOI: 10.1136/gut.23.12.1037

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Complement and host defense against infection.

Authors:  R B Johnston; R M Stroud
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

Review 2.  The treatment of acute liver failure.

Authors:  S J Saunders; R Hickman; R Macdonald; J Terblanche
Journal:  Prog Liver Dis       Date:  1972

3.  Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.

Authors:  S P Wilkinson; V Arroyo; B G Gazzard; H Moodie; R Williams
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

4.  Homozygous deficiency of C3 in a patient with repeated infections.

Authors:  C A Alper; H R Colten; F S Rosen; A R Rabson; G M Macnab; J S Gear
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

5.  Microbiological monitoring of patients in hepatic failure with particular reference to extracorporeal porcine liver perfusion.

Authors:  R V Mummery; J M Bradley; D J Jeffries
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

6.  Proceedings: Renal failure and site of abnormal renal retention of sodium in fulminant hepatic failure.

Authors:  S P Wilkinson; V Arroyo; H E Moodie; L M Blendis; R Williams
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

7.  Opsonic activity in the newborn: role of properdin.

Authors:  T P Stossel; C A Alper; F S Rosen
Journal:  Pediatrics       Date:  1973-07       Impact factor: 7.124

Review 8.  The management of fulminant hepatic failure.

Authors:  C Trey; C S Davidson
Journal:  Prog Liver Dis       Date:  1970

9.  Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

Authors:  A Martin; P J Lachmann; L Halbwachs; M J Hobart
Journal:  Immunochemistry       Date:  1976-04

10.  Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage.

Authors:  B G Gazzard; B Portmann; I M Murray-Lyon; R Williams
Journal:  Q J Med       Date:  1975-10
View more
  9 in total

Review 1.  Infections.

Authors:  N Rolando; R J Wyke
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Surveillance for infectious complications in pediatric acute liver failure - a prospective study.

Authors:  Suresh Mekala; Barath Jagadisan; Subhash Chandra Parija; Subitha Lakshminarayanan
Journal:  Indian J Pediatr       Date:  2014-06-20       Impact factor: 1.967

3.  Experimental candidiasis in liver injury.

Authors:  F Abe; S Nagata; M Hotchi
Journal:  Mycopathologia       Date:  1987-10       Impact factor: 2.574

Review 4.  Problems of bacterial infection in patients with liver disease.

Authors:  R J Wyke
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

5.  Early diagnosis of bacterial and fungal infection in chronic cholestatic hepatitis B.

Authors:  Xiong-Zhi Wu; Dan Chen; Lian-San Zhao; Xiao-Hui Yu; Mei Wei; Yan Zhao; Qing Fang; Qian Xu
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 6.  [Acute liver failure].

Authors:  K Rifai; M J Bahr
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

7.  A common congenital immunodeficiency predisposing to infection and atopy in infancy.

Authors:  V F Richardson; V F Larcher; J F Price
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

8.  Complement levels in patients with hepatic dysfunction.

Authors:  R T Ellison; C R Horsburgh; J Curd
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

9.  Experimental candidiasis associated with liver injury. Role of transferrin.

Authors:  F Abe; T Katoh; H Inaba; M Hotchi
Journal:  Mycopathologia       Date:  1988-10       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.